These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5131632)

  • 21. Effect of 5,5'-diphenylhydantoin on the metabolism of L-thyroxine-131-I in the rat.
    Mendoza DM; Flock EV; Owen CA; Paris J
    Endocrinology; 1966 Jul; 79(1):106-18. PubMed ID: 4161992
    [No Abstract]   [Full Text] [Related]  

  • 22. Proceedings: UDP-glucuronyltransferase in perfused rat liver and in microsomes: influence of phenobarbital and 3-methylcholanthrene.
    Bock KW; Schwarz LR; White IN
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R10. PubMed ID: 4276523
    [No Abstract]   [Full Text] [Related]  

  • 23. [Influence of a beta-blocking drug on the clearance time of thyroxine-I-125 from plasma in rats].
    Dogliotti L; Fonzo D; Lauro R; De Martinis C
    Boll Soc Ital Biol Sper; 1968 Feb; 44(4):300-3. PubMed ID: 5677873
    [No Abstract]   [Full Text] [Related]  

  • 24. Ehanced biliary thyroxine excretion in rats treated with pregnenolone-16alpha-carbonitrile.
    Japundzić MM; Bastomsky CH; Japundzić IP
    Acta Endocrinol (Copenh); 1976 Jan; 81(1):110-9. PubMed ID: 946136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucuronidation of thyroxine in primary monolayer cultures of rat hepatocytes: in vitro induction of UDP-glucuronosyltranferases by methylcholanthrene, clofibrate, and dexamethasone alone and in combination.
    Jemnitz K; Veres Z; Monostory K; Vereczkey L
    Drug Metab Dispos; 2000 Jan; 28(1):34-7. PubMed ID: 10611137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased biliary excretion of thyroxine by microsomal enzyme inducers.
    Vansell NR; Klaassen CD
    Toxicol Appl Pharmacol; 2001 Nov; 176(3):187-94. PubMed ID: 11714251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of red blood cells, serum albumin, and serum lipoproteins on the clearance of benzo[alpha]pyrene by isolated livers of 3-methylcholanthrene-treated rats.
    Wiersma DA; Stemmer PM; Roth RA
    Biochem Pharmacol; 1984 Nov; 33(21):3433-8. PubMed ID: 6497903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total body clearance of circulating benzo(a)pyrene in conscious rats: effect of pretreatment with 3-methylcholanthrene and the role of liver and lung.
    Wiersma DA; Roth RA
    J Pharmacol Exp Ther; 1983 Sep; 226(3):661-7. PubMed ID: 6310077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism and distribution of triiodothyronine and thyroxine in the bullfrog tadpole.
    Ashley H; Frieden E
    Gen Comp Endocrinol; 1972 Feb; 18(1):22-31. PubMed ID: 4536678
    [No Abstract]   [Full Text] [Related]  

  • 30. Male rat hepatic UDP-glucuronosyltransferase activity toward thyroxine. Activation and induction properties--relation with thyroxine plasma disappearance rate.
    de Sandro V; Catinot R; Kriszt W; Cordier A; Richert L
    Biochem Pharmacol; 1992 Apr; 43(7):1563-9. PubMed ID: 1567478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Qualitative and quantitative aspects of thyroxine metabolism in sheep.
    Irvine CH
    Endocrinology; 1969 Oct; 85(4):662-73. PubMed ID: 4979515
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of phenobarbital & 3-methylcholanthrene treatment on thyroid hormones in rat.
    Khanduja KL; Gupta MP; Pathak CM; Vaidyanathan S; Koul A; Koul IB; Sharma RR
    Indian J Med Res; 1987 Sep; 86():375-81. PubMed ID: 3428972
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of hepatic microsomal enzyme inducers on the pharmacokinetics of ouabain after portal and systemic administration to rats.
    Thompson TN; Klaassen CD
    J Pharm Pharmacol; 1995 Dec; 47(12A):1041-7. PubMed ID: 8932692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of phenolic- and tyrosyl-ring labeled L-thyroxine in human beings and rats.
    Surks MI; Oppenheimer JH
    J Clin Endocrinol Metab; 1971 Oct; 33(4):612-8. PubMed ID: 5093766
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of 3-methylcholanthrene and thyroxine on in vitro metabolism of aniline and N-methylbenzoylaniline].
    Oga S; Cebrian C; Reis A; Kitagawa H
    Rev Bras Pesqui Med Biol; 1973; 6(3):125-30. PubMed ID: 4728807
    [No Abstract]   [Full Text] [Related]  

  • 36. Relation between the biliary clearance rate of thyroxine and the binding of thyroxine by the serum proteins.
    MYANT NB
    J Physiol; 1957 Feb; 135(2):426-41. PubMed ID: 13406751
    [No Abstract]   [Full Text] [Related]  

  • 37. Biliary secretion of thyroxine in rats with thyroid-depressing hypothalamic lesions.
    Averill RL; Newman WC
    Endocrinology; 1969 Apr; 84(4):950-2. PubMed ID: 5766550
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased plasma clearance rate of thyroxine despite decreased 5'-monodeiodination: study with a peroxisome proliferator in the rat.
    Kaiser CA; Seydoux J; Giacobino JP; Girardier L; Burger AG
    Endocrinology; 1988 Mar; 122(3):1087-93. PubMed ID: 3342745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of 3-methylcholanthrene pretreatment on glucuronidation and sulfation in perfused rat liver.
    Hamada N; Gessner T
    Drug Metab Dispos; 1975; 3(5):407-16. PubMed ID: 241622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid hormone secretion rate and biological half-life (t one half) of L-thyroxine-131 I in the musk shrew (Suncus murinus).
    Dryden GL; Bauman TR; Conaway CH; Anderson RR
    Gen Comp Endocrinol; 1969 Jun; 12(3):536-40. PubMed ID: 4181507
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.